Cevostamab (Anti- FcRH5 / IRTA2 / CD307e)

Synonyms: BFCR 4350A; RG 6160; RO 7187797

Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) is a humanized IgG1-based bispecific antibody that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. MW: 145.24 kD.

Cevostamab (Anti- FcRH5 / IRTA2 / CD307e)

Purity & Quality Control

Biological Activity

Description Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) is a humanized IgG1-based bispecific antibody that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. MW: 145.24 kD.

Product Details

CAS No. 2249888-53-5
Molecular Weight 145.24
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) | Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) supplier | purchase Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) | Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) cost | Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) manufacturer | order Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) | Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) distributor